慢性慢性肺炎的药理管理
1Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK; Medicines Evaluation Unit an IQVIA Business, Manchester, UK.
新的药理疗法,包括dupilumab和ensifentrine等生物药物,通过改善症状缓解和预防恶化,正在推进慢性阻塞性肺病 (COPD) 管理.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
- 呼吸系统疾病 呼吸系统疾病
背景情况:
- 慢性阻塞性肺病 (COPD) 的药理管理优先考虑缓解症状和预防恶化.
- 吸入疗法,包括与长效支气管扩展剂和吸入皮质类固醇 (ICS) 的联合吸入器,是治疗COPD的标准.
- 个性化的方法,如使用血中乙氨基酸计数来指导ICS治疗,越来越重要.
研究的目的:
- 审查COPD药理学的最新进展.
- 涵盖COPD管理中的新分子,新兴证据和不断发展的临床实践.
主要方法:
- 关于COPD药理治疗的当前文献的综述.
- 对新治疗剂的临床试验数据的分析.
- 检查临床实践指南的变化.
主要成果:
- 组合吸入器具有实用优势,并且基于临床证据被广泛使用.
- 血中乙氨基酸计数有助于为COPD患者个性化吸入性皮质类固醇 (ICS) 治疗.
- 生物治疗方法,包括dupilumab和ensifentrine,在COPD的临床试验中显示出希望.
结论:
- 新型药理学药物,如dupilumab和ensifentrine在COPD治疗方面取得了重大进展.
- 未来的COPD管理可能将包括精准医学方法与生物疗法.
- 持续的研究和证据对于完善COPD药理策略至关重要.
更多相关视频
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
05:34Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
Published on: August 18, 2023
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Chronic Obstructive Pulmonary Disease-I: Introduction
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
